Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15451 - 15475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Bortezomib	Approved Investigational	RNF11	26994	upregulated	Bortezomib results in increased expression of RNF11 mRNA	1p32.3	A21434
Bortezomib	Approved Investigational	RNF138	51444	upregulated	Bortezomib results in increased expression of RNF138 mRNA	18q12.1	A21434
Bortezomib	Approved Investigational	RNF14	9604	upregulated	Bortezomib results in increased expression of RNF14 mRNA	5q31.3	A21434
Bortezomib	Approved Investigational	RNF2	6045	upregulated	Bortezomib results in increased expression of RNF2 mRNA	1q25.3	A21434
Bortezomib	Approved Investigational	RPA3	6119	downregulated	Bortezomib results in decreased expression of RPA3 mRNA	7p21.3	A21437
Bortezomib	Approved Investigational	RPAP3	79657	upregulated	Bortezomib results in increased expression of RPAP3 mRNA	12q13.11	A21434
Bortezomib	Approved Investigational	RPL13P5	283345	upregulated	Bortezomib results in increased expression of RPL13P5 mRNA	12p13.31	A21434
Bortezomib	Approved Investigational	RPL26	6154	upregulated	Bortezomib results in increased expression of RPL26 mRNA	17p13.1	A21434
Bortezomib	Approved Investigational	RPS11	6205	upregulated	Bortezomib results in increased expression of RPS11 mRNA	19q13.3	A21434
Bortezomib	Approved Investigational	RPS19	6223	upregulated	Bortezomib results in increased expression of RPS19 mRNA	19q13.2	A21440
Bortezomib	Approved Investigational	RPS6KB1	6198	upregulated	Bortezomib results in increased expression of RPS6KB1 mRNA	17q23.1	A21434
Bortezomib	Approved Investigational	RPS6KC1	26750	upregulated	Bortezomib results in increased expression of RPS6KC1 mRNA	1q32.3	A21434
Bortezomib	Approved Investigational	RPS7P5	645884	downregulated	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of RPS7P5 mRNA	1q43	A21436
Bortezomib	Approved Investigational	RRM2B	50484	upregulated	Bortezomib results in increased expression of RRM2B mRNA	8q22.3	A21434
Bortezomib	Approved Investigational	RSU1	6251	upregulated	Bortezomib results in increased expression of RSU1 mRNA	10p13	A21434
Bortezomib	Approved Investigational	SAFB	6294	downregulated	Bortezomib results in decreased expression of SAFB mRNA	19p13.3	A21434
Bortezomib	Approved Investigational	SAMD10	140700	downregulated	Bortezomib results in decreased expression of SAMD10 mRNA	20q13.33	A21434
Bortezomib	Approved Investigational	SCARNA17	677769	upregulated	Bortezomib results in increased expression of SCARNA17 mRNA	18q21.1	A21434
Bortezomib	Approved Investigational	SCD	6319	downregulated	Bortezomib results in decreased expression of SCD mRNA	10q24.31	A21434
Bortezomib	Approved Investigational	SCHIP1	29970	downregulated	Bortezomib results in decreased expression of SCHIP1 mRNA	3q25.33	A21434
Bortezomib	Approved Investigational	SCPEP1	59342	upregulated	Bortezomib results in increased expression of SCPEP1 mRNA	17q22	A21434
Bortezomib	Approved Investigational	SDHC	6391	downregulated	Bortezomib results in decreased expression of SDHC mRNA	1q23.3	A21434
Bortezomib	Approved Investigational	SELENOK	58515	upregulated	Bortezomib results in increased expression of SELENOK mRNA	3p21.1	A21434
Bortezomib	Approved Investigational	SENP3	26168	downregulated	Bortezomib results in decreased expression of SENP3 mRNA	17p13	A21434
Bortezomib	Approved Investigational	SETD1B	23067	upregulated	Bortezomib results in increased expression of SETD1B mRNA	12q24.31	A21434

Displaying entries 15451 - 15475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability